Eton Pharmaceuticals Inc
ETON18.460USD
+0.780+4.41%
Close 09/18, 16:00（ET）Quotes delayed by 15 min
495.05MMarket Cap
LossP/E TTM
More Details of Eton Pharmaceuticals Inc Company
Eton Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company has six commercial rare disease products: INCRELEX, ALKINDI SPRINKLE, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous, and Nitisinone. INCRELEX is a biologic product used to treat pediatric patients 2 years of age and older who suffer from severe primary insulin-like growth factor 1 deficiency (SPIGFD). ALKINDI SPRINKLE is for the treatment of pediatric adrenocortical insufficiency. Carglumic Acid is for the treatment of hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency. Betaine Anhydrous is for the treatment of homocystinuria. Nitisinone is for the treatment of hereditary tyrosinemia type 1 (HT-1). PKU GOLIKE is a medical formula for patients with phenylketonuria (PKU). Galzin, its product, is FDA-approved for the treatment of the ultra-rare metabolic condition of Wilson Disease.
Company Info
Ticker SymbolETON
Company nameEton Pharmaceuticals Inc
IPO dateNov 09, 2018
CEOMr. Sean E. Brynjelsen
Number of employees31
Security typeOrdinary Share
Fiscal year-endNov 09
Address21925 W Field Pkwy Ste 235
CityDEER PARK
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code60010-7278
Phone18477877361
Websitehttps://etonpharma.com/
Ticker SymbolETON
IPO dateNov 09, 2018
CEOMr. Sean E. Brynjelsen
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Sean E. Brynjelsen
Mr. Sean E. Brynjelsen
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
864.94K
-19.54%
Mr. Charles J. (Chuck) Casamento
Mr. Charles J. (Chuck) Casamento
Independent Director
Independent Director
93.42K
--
Mr. Paul V. Maier
Mr. Paul V. Maier
Independent Director
Independent Director
84.75K
--
Dr. Norbert G. Riedel, Ph.D.
Dr. Norbert G. Riedel, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
84.75K
-54.72%
Mr. James R. Gruber
Mr. James R. Gruber
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
21.71K
-34.20%
Ms. Ipek Erdogan-Trinkaus
Ms. Ipek Erdogan-Trinkaus
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. David C. Krempa
Mr. David C. Krempa
Chief Business Officer
Chief Business Officer
--
--
Ms. Jennifer (Jenn) Adams
Ms. Jennifer (Jenn) Adams
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Sean E. Brynjelsen
Mr. Sean E. Brynjelsen
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
864.94K
-19.54%
Mr. Charles J. (Chuck) Casamento
Mr. Charles J. (Chuck) Casamento
Independent Director
Independent Director
93.42K
--
Mr. Paul V. Maier
Mr. Paul V. Maier
Independent Director
Independent Director
84.75K
--
Dr. Norbert G. Riedel, Ph.D.
Dr. Norbert G. Riedel, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
84.75K
-54.72%
Mr. James R. Gruber
Mr. James R. Gruber
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
21.71K
-34.20%
Ms. Ipek Erdogan-Trinkaus
Ms. Ipek Erdogan-Trinkaus
Chief Commercial Officer
Chief Commercial Officer
--
--
Revenue Breakdown
FY2025Q1
FY2024
No Data
By RegionUSD
Name
Revenue
Proportion
United States
17.28M
0.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, Aug 23
Updated: Sat, Aug 23
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Opaleye Management Inc.
10.66%
EcoR1 Capital, LLC
7.57%
BlackRock Institutional Trust Company, N.A.
5.22%
The Vanguard Group, Inc.
4.89%
Nantahala Capital Management, LLC
4.38%
Other
67.27%
Shareholders
Shareholders
Proportion
Opaleye Management Inc.
10.66%
EcoR1 Capital, LLC
7.57%
BlackRock Institutional Trust Company, N.A.
5.22%
The Vanguard Group, Inc.
4.89%
Nantahala Capital Management, LLC
4.38%
Other
67.27%
Shareholder Types
Shareholders
Proportion
Hedge Fund
21.78%
Investment Advisor/Hedge Fund
19.63%
Investment Advisor
17.64%
Individual Investor
4.30%
Research Firm
3.05%
Pension Fund
0.37%
Bank and Trust
0.10%
Insurance Company
0.04%
Other
33.10%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
158
16.03M
59.76%
-1.46M
2025Q1
154
15.73M
58.88%
-1.49M
2024Q4
125
14.61M
54.85%
+562.47K
2024Q3
98
10.99M
42.37%
-1.69M
2024Q2
94
9.67M
37.40%
-2.32M
2024Q1
94
10.57M
41.25%
-1.37M
2023Q4
96
10.49M
40.94%
-1.03M
2023Q3
99
10.24M
39.99%
-325.57K
2023Q2
102
9.33M
36.53%
-1.39M
2023Q1
130
9.22M
36.30%
-1.78M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Opaleye Management Inc.
2.86M
10.66%
+7.93K
+0.28%
Jun 10, 2025
EcoR1 Capital, LLC
1.94M
7.23%
+109.69K
+6.00%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
322.25K
1.2%
+23.51K
+7.87%
Mar 31, 2025
The Vanguard Group, Inc.
1.10M
4.11%
+37.26K
+3.50%
Mar 31, 2025
Nantahala Capital Management, LLC
1.18M
4.38%
+57.47K
+5.14%
Mar 31, 2025
Brynjelsen (Sean E)
864.94K
3.23%
-210.00K
-19.54%
Jun 05, 2025
Geode Capital Management, L.L.C.
298.25K
1.11%
+29.60K
+11.02%
Mar 31, 2025
Westside Investment Management, LLC
493.65K
1.84%
-81.57K
-14.18%
Mar 31, 2025
Renaissance Technologies LLC
274.00K
1.02%
+80.90K
+41.90%
Mar 31, 2025
View more
Related ETFs
Updated: Tue, Sep 2
Updated: Tue, Sep 2
Name
Proportion
iShares Micro-Cap ETF
0.08%
Vanguard US Momentum Factor ETF
0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.05%
iShares Russell 2000 Growth ETF
0.02%
iShares Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
Dimensional US Core Equity 1 ETF
0%
View more
iShares Micro-Cap ETF
Proportion0.08%
Vanguard US Momentum Factor ETF
Proportion0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.05%
iShares Russell 2000 Growth ETF
Proportion0.02%
iShares Russell 2000 ETF
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
Dimensional US Core Equity 1 ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
